Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Health
Tara Cosoleto

First vaccine approved for infectious respiratory virus

The TGA has approved a respiratory syncytial virus vaccine for Australians aged 60 and over. (Joel Carrett/AAP PHOTOS)

A vaccine to combat a highly infectious respiratory disease has been approved for use in Australia for the first time. 

The Therapeutic Goods Administration has ticked off AREXVY to be used as a respiratory syncytial virus vaccine for Australians aged 60 and over. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.